Gilead Sciences

Gilead Sciences' Kite Pharma Deal Has Already Paid for Itself -- for Investors
Gilead Sciences' Kite Pharma Deal Has Already Paid for Itself -- for Investors
Motley Fool
Gilead Sciences
Kite Pharma
M&A
investors
Flag link:
Bayer gears up to take on Gilead in lymphoma with Aliqopa green light
Bayer gears up to take on Gilead in lymphoma with Aliqopa green light
Fierce Pharma
Bayer
Gilead Sciences
Aliqopa
copanlisib
relapsed follicular lymphoma
Flag link:
5 Tough Questions for Gilead Sciences About the Kite Pharma Acquisition
5 Tough Questions for Gilead Sciences About the Kite Pharma Acquisition
Motley Fool
Gilead Sciences
Kite Pharma
M&A
axi-cel
pay-for-performance
Flag link:
How Kite came from a position of strength to get Gilead to boost its buyout price by 42%
How Kite came from a position of strength to get Gilead to boost its buyout price by 42%
Fierce Pharma
Kite Pharma
Gilead Sciences
Flag link:
5 Things Gilead Sciences' Management Just Said That You'll Want to Know
5 Things Gilead Sciences' Management Just Said That You'll Want to Know
Motley Fool
Gilead Sciences
Kite Pharma
HIV
hepatitis C
M&A
Flag link:
Here’s the inside account of Gilead’s 11-week sprint to its $12B Kite buyout
Here’s the inside account of Gilead’s 11-week sprint to its $12B Kite buyout
Endpoints
Gilead Sciences
Kite Pharma
M&A
Flag link:
Gilead Sciences Couldn't Have Timed its Splash Into CAR-T Better
Gilead Sciences Couldn't Have Timed its Splash Into CAR-T Better
Motley Fool
Gilead Sciences
CAR-T
Kite Pharma
M&A
Flag link:
The Only 2 Biotech Stocks With a Higher Dividend Yield Than the S&P 500
The Only 2 Biotech Stocks With a Higher Dividend Yield Than the S&P 500
Motley Fool
biotech stocks
Amgen
Gilead Sciences
Flag link:
3 Reasons Gilead Sciences Jumped to Buy Kite Pharma
3 Reasons Gilead Sciences Jumped to Buy Kite Pharma
Motley Fool
Gilead Sciences
Kite Pharma
M&A
Flag link:
Why bluebird bio Inc Continued Its March Higher Again Today
Why bluebird bio Inc Continued Its March Higher Again Today
Motley Fool
Bluebird Bio
bb2121
CAR-T
Novartis
Kymriah
Gilead Sciences
Kite Pharma
Flag link:
Novartis $475,000 Price Tag Sets the Stage for a Price War With Gilead Sciences
Novartis $475,000 Price Tag Sets the Stage for a Price War With Gilead Sciences
Motley Fool
Novartis
CAR-T
Kymriah
Gilead Sciences
Kite Pharma
M&A
Flag link:
Kite chief Arie Belldegrun up for $600M-plus payday from Gilead buyout
Kite chief Arie Belldegrun up for $600M-plus payday from Gilead buyout
Fierce Pharma
Kite Pharma
Gilead Sciences
M&A
executive pay
Arie Belldegrun
Flag link:
Biotech: Back In Vogue
Biotech: Back In Vogue
Barron's
biotech
biotech stocks
Gilead Sciences
M&A
Kite Pharma
Flag link:
Infographic | The leaders of the global hepatitis-C market
Infographic | The leaders of the global hepatitis-C market
Medical Marketing and Media
hepatitis C
Gilead Sciences
Merck
AbbVie
Bristol-Myers Squibb
Flag link:
Has Gilead Sciences' Big Bounce Begun With the Kite Pharma Buyout?
Has Gilead Sciences' Big Bounce Begun With the Kite Pharma Buyout?
Motley Fool
Gilead Sciences
CAR-T
Kite Pharma
M&A
Flag link:
Get Ready for More Acquisitions by Gilead Sciences
Get Ready for More Acquisitions by Gilead Sciences
Motley Fool
Gilead Sciences
M&A
Kite Pharma
Ziopharm
Flag link:
AIDS activists urge N.Y. attorney general to probe Gilead for antitrust violations
AIDS activists urge N.Y. attorney general to probe Gilead for antitrust violations
Stat
Gilead Sciences
Truvada
antitrust
AIDS
HIV
Flag link:
How will Gilead price CAR-T? With Kite buy, the top biotech joins Novartis in spotlight
How will Gilead price CAR-T? With Kite buy, the top biotech joins Novartis in spotlight
Fierce Pharma
Gilead Sciences
Kite Pharma
CAR-T
drug pricing
M&A
Flag link:
Here's What Else Gilead Sciences Gets by Buying Kite Pharma
Here's What Else Gilead Sciences Gets by Buying Kite Pharma
Motley Fool
Gilead Sciences
Kite Pharma
M&A
CAR-T
TCR-targeted drugs
Flag link:
To Be More Than a Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles
To Be More Than a Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles
Xconomy
Gilead Sciences
Kite Pharma
M&A
CAR-T
Flag link: